共 266 条
[21]
Kerr SJ(2021)Physician visits and medication prescriptions for major chronic diseases during the COVID-19 pandemic in Japan: retrospective cohort study BMJ (Open) 11 e050938-1256
[22]
McComsey GA(2017)Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium Arch Osteoporos 12 58-2411
[23]
Lupo S(1973)Interpretation of serum calcium in patients with abnormal serum proteins Br Med J 4 643-2978
[24]
Parks D(2014)Changes in bone mineral density may predict the risk of fracture differently in older adults according to fall history J Am Geriatr Soc 62 2345-545
[25]
Poggio MC(2013)Denosumab significantly increases DXA BMD at both trabecular and cortical sites: results from the freedom study J Clin Densitom 16 147-1020
[26]
De Wet J(2022)Romosozumab and antiresorptive treatment: the importance of treatment sequence Osteoporos Int 33 1243-4971
[27]
Kahl LP(2015)Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis Osteoporos Int 26 2401-1218
[28]
Wells GA(2016)GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab Osteoporos Int 27 2967-22
[29]
Cranney A(2017)Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates Arch Osteoporos 13 1-14
[30]
Peterson J(2020)Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK clinical practice research datalink Osteoporos Int 31 533-54